We are live on
!
Find out more
US Bancorp Portfolio holdings
AUM
$82.4B
1-Year Est. Return
19.69%
This Fund
S&P 500
This Quarter
Est. Return
+8.01%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$39.1B
AUM Growth
+$2.42B
(+6.6%)
Cap. Flow
-$248M
Cap. Flow
% of AUM
-0.63%
Top 10 Holdings %
Top 10 Hldgs %
22.64%
Holding
3,845
New
218
Increased
1,110
Reduced
1,483
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell Mid-Cap ETF
IWR
|
+$45.6M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$40.7M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$38.8M |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$35.5M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$34.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$80.2M |
| 2 |
Copart
CPRT
|
+$55.9M |
| 3 |
US Bancorp
USB
|
+$47.8M |
| 4 |
IBDK
iShares iBonds Dec 2019 Term Corporate ETF
IBDK
|
+$25.8M |
| 5 |
iShares Floating Rate Bond ETF
FLOT
|
+$17.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.27% |
| 2 | Financials | 10.78% |
| 3 | Industrials | 9.91% |
| 4 | Healthcare | 9.19% |
| 5 | Consumer Staples | 6.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Oracle
ORCL
$346B
| $82.7M | 0.21% |
1,560,578
-19,965
| -1% | -$1.1M |
|
102
Starbucks
SBUX
$118B
| $82.7M | 0.21% |
940,316
-24,480
| -3% | -$2.09M |
|
103
Gilead Sciences
GILD
$162B
| $81.6M | 0.21% |
1,255,290
+12,388
| +1% | +$807K |
|
104
Vanguard Extended Market ETF
VXF
$30.4B
| $80.2M | 0.2% |
636,284
+21,719
| +4% | +$2.62M |
|
105
Vanguard FTSE Emerging Markets ETF
VWO
$119B
| $79.7M | 0.2% |
1,791,121
+345,772
| +24% | +$14.6M |
|
106
iShares Russell 3000 ETF
IWV
$19.5B
| $77.7M | 0.2% |
412,376
-1,947
| -0.5% | -$351K |
|
107
Philip Morris
PM
$298B
| $76M | 0.19% |
893,223
-34,833
| -4% | -$2.87M |
|
108
iShares Core MSCI Total International Stock ETF
IXUS
$57.6B
| $75.7M | 0.19% |
1,223,679
+17,558
| +1% | +$1.05M |
|
109
SPDR Gold Trust
GLD
$130B
| $75.6M | 0.19% |
529,077
+11,462
| +2% | +$1.6M |
|
|
SPLK
110
DELISTED
Splunk Inc
SPLK
| $75.5M | 0.19% |
503,834
+50,421
| +11% | +$6.62M |
|
111
Illinois Tool Works
ITW
$79.7B
| $75.3M | 0.19% |
419,307
-12,514
| -3% | -$2.12M |
|
112
iShares Russell 2000 Growth ETF
IWO
$14.6B
| $74.5M | 0.19% |
347,651
+20,780
| +6% | +$4.22M |
|
113
Cincinnati Financial
CINF
$27.7B
| $73.5M | 0.19% |
698,838
-7,912
| -1% | -$865K |
|
114
Centene
CNC
$31.5B
| $72.8M | 0.19% |
1,157,431
+68,345
| +6% | +$3.71M |
|
115
C.H. Robinson
CHRW
$24.2B
| $72.4M | 0.19% |
926,372
-23,088
| -2% | -$1.84M |
|
116
iShares Intermediate Government/Credit Bond ETF
GVI
$3.72B
| $71.9M | 0.18% |
637,949
-12,364
| -2% | -$1.4M |
|
117
S&P Global
SPGI
$124B
| $71M | 0.18% |
260,194
-10,229
| -4% | -$2.66M |
|
118
PNC Financial Services
PNC
$99.5B
| $70.8M | 0.18% |
443,540
-30,455
| -6% | -$4.57M |
|
119
iShares US Real Estate ETF
IYR
$4.49B
| $70.5M | 0.18% |
757,875
-25,883
| -3% | -$2.4M |
|
|
RTN
120
DELISTED
Raytheon Company
RTN
| $70.1M | 0.18% |
319,011
-19,916
| -6% | -$4.21M |
|
121
Colgate-Palmolive
CL
$72.1B
| $69.8M | 0.18% |
1,014,607
-41,574
| -4% | -$2.83M |
|
122
iShares Short-Term National Muni Bond ETF
SUB
$11.3B
| $68.7M | 0.18% |
643,343
+57,913
| +10% | +$6.18M |
|
123
iShares Currency Hedged MSCI EAFE ETF
HEFA
$7.41B
| $67.5M | 0.17% |
2,213,086
+240,929
| +12% | +$7.35M |
|
124
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
| $67.4M | 0.17% |
766,793
+177,624
| +30% | +$15.5M |
|
125
Thermo Fisher Scientific
TMO
$213B
| $67.2M | 0.17% |
206,856
-2,610
| -1% | -$791K |
|
Similar funds
US Bancorp's Q4 2019 Portfolio in Review
As of Q4 2019, US Bancorp held 3,845 positions worth $39.1B, up 6.6% from $36.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
US Bancorp's Q4 2019 filing shows 218 new, 1,110 increased, 1,483 reduced and 148 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M. The largest sale was Celgene Corp, an estimated $80.2M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.
- US Bancorp's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M.
- US Bancorp added most to iShares Russell Mid-Cap ETF in Q4 2019, an estimated $45.6M increase.
- US Bancorp's biggest Q4 2019 reduction was Copart, cutting an estimated $55.9M.
- US Bancorp fully exited Celgene Corp in Q4 2019, selling an estimated $80.2M.
- US Bancorp's ten largest holdings make up 23% of its $39.1B portfolio in Q4 2019.
- US Bancorp opened 218 new positions and closed 148 in Q4 2019.
- US Bancorp's portfolio value rose 6.6% quarter-over-quarter to $39.1B.
Based on US Bancorp's 13F filing for Q4 2019, filed 4 Feb 2020.